The virtual assay software for human in silico drug trials to augment drug cardiac testing

The virtual assay software for human in silico drug trials to augment drug cardiac testing

Prediction of drug effects on the heart still represents a challenge in drug development, given potential adverse outcomes. Computer modelling and simulations of the human heart offer a powerful technology to augment existing animal and clinical methodologies. Here we describe the translation proces...

Volledige beschrijving

Bibliografische gegevens
Hoofdauteurs:	Passini, E, Zhou, X, Trovato, C, Britton, OJ, Bueno-Orovio, A, Rodriguez, B
Formaat:	Journal article
Taal:	English
Gepubliceerd in:	Elsevier 2020

Gelijkaardige items

Drug‐induced shortening of the electromechanical window is an effective biomarker for in silico prediction of clinical risk of arrhythmias
door: Passini, E, et al.
Gepubliceerd in: (2019)

Blinded in silico drug trial reveals the minimum set of ion channels for torsades de pointes risk assessment
door: Zhou, X, et al.
Gepubliceerd in: (2020)

Cross clinical-experimental-computational qualification of in silico drug trials on human cardiac purkinje cells for proarrhythmia risk prediction
door: Cristian Trovato, et al.
Gepubliceerd in: (2022-10-01)

Human in silico drug trials demonstrate higher accuracy than animal models in predicting clinical pro-arrhythmic cardiotoxicity
door: Passini, E, et al.
Gepubliceerd in: (2017)

P511 In silico trials in human ventricular and purkinje cell models predict safety and efficacy of 10 antiarrhythmic drugs
door: Trovato, C, et al.
Gepubliceerd in: (2017)

Variability in cardiac electrophysiology: Using experimentally-calibrated populations of models to move beyond the single virtual physiological human paradigm.
door: Muszkiewicz, A, et al.
Gepubliceerd in: (2015)

In-silico drug trials for precision medicine in atrial fibrillation: from ionic mechanisms to electrocardiogram-based predictions in structurally-healthy human atria
door: Dasí, A, et al.
Gepubliceerd in: (2022)

In-silico drug trials for precision medicine in atrial fibrillation: From ionic mechanisms to electrocardiogram-based predictions in structurally-healthy human atria
door: Albert Dasí, et al.
Gepubliceerd in: (2022-09-01)

In silico evaluation of arrhythmia
door: Zhou, X, et al.
Gepubliceerd in: (2017)

What determines the optimal pharmacological treatment of atrial fibrillation? Insights from in silico trials in 800 virtual atria
door: Dasí, A, et al.
Gepubliceerd in: (2023)

Is it time for in silico simulation of drug cardiac side effects?
door: Mirams, G, et al.
Gepubliceerd in: (2011)

Is it time for in silico simulation of drug cardiac side effects?
door: Mirams, G, et al.
Gepubliceerd in: (2011)

Development, calibration, and validation of a novel human ventricular myocyte model in health, disease, and drug block
door: Tomek, J, et al.
Gepubliceerd in: (2019)

In-silico human electro-mechanical ventricular modelling and simulation for drug-induced pro-arrhythmia and inotropic risk assessment
door: Margara, F, et al.
Gepubliceerd in: (2020)

Development, calibration, and validation of a novel human ventricular myocyte model in health, disease, and drug block
door: Jakub Tomek, et al.
Gepubliceerd in: (2019-12-01)

Virtual and Augmented Reality in Cardiac Surgery
door: Arian Arjomandi Rad, et al.
Gepubliceerd in: (2021-12-01)

Toward a broader view of mechanisms of drug cardiotoxicity
door: Mamoshina, P, et al.
Gepubliceerd in: (2021)

In vitro Assays and Imaging Methods for Drug Discovery for Cardiac Fibrosis
door: Giorgia Palano, et al.
Gepubliceerd in: (2021-07-01)

Natural Lipid Extracts as an Artificial Membrane for Drug Permeability Assay: In Vitro and In Silico Characterization
door: Anna Vincze, et al.
Gepubliceerd in: (2023-03-01)

VirtualToxLab – in silico Prediction of the Endocrine-Disrupting Potential of Drugs and Chemicals
door: Angelo Vedani, et al.
Gepubliceerd in: (2008-05-01)

All-optical electrophysiology refines populations of in silico human iPSC-CMs for drug evaluation
door: Paci, M, et al.
Gepubliceerd in: (2020)

Potential Drug-Drug Interactions in a Cardiac Center: Development of Simple Software for Pattern Identification
door: Fatemeh Rangraz Jeddi, et al.
Gepubliceerd in: (2022-10-01)

On the Integration of In Silico Drug Design Methods for Drug Repurposing
door: Eric March-Vila, et al.
Gepubliceerd in: (2017-05-01)

Dual transcriptomic and molecular machine learning predicts all major clinical forms of drug cardiotoxicity
door: Mamoshina, P, et al.
Gepubliceerd in: (2020)

The STEM teachers' course "Development of virtual and augmented reality software"
door: Mykhailo Mintii
Gepubliceerd in: (2021-09-01)

Drug susceptibility testing of Mycobacterium tuberculosis using next generation sequencing and Mykrobe software
door: V. Tolchkov, et al.
Gepubliceerd in: (2022-01-01)

Human ventricular modelling and simulation of drug action on electrophysiology and contraction
door: Margara, F, et al.
Gepubliceerd in: (2021)

Cheburator software for automatically calculating drug inhibitory concentrations from in vitro screening assays.
door: Dmitry Nevozhay
Gepubliceerd in: (2014-01-01)

Enhanced drug classification using machine learning with multiplexed cardiac contractility assays
door: Reza Aghavali, et al.
Gepubliceerd in: (2024-11-01)

Explainable artificial intelligence (XAI) to find optimal in-silico biomarkers for cardiac drug toxicity evaluation
door: Muhammad Adnan Pramudito, et al.
Gepubliceerd in: (2024-10-01)

A new classifier-based strategy for in-silico ion-channel cardiac drug safety assessment
door: Hitesh eMistry, et al.
Gepubliceerd in: (2015-03-01)

The importance of in-silico studies in drug discovery
door: Roney, Miah, et al.
Gepubliceerd in: (2024)

A Guide to In Silico Drug Design
door: Yiqun Chang, et al.
Gepubliceerd in: (2022-12-01)

An integrated dataset for in silico drug discovery
door: Cockell Simon J, et al.
Gepubliceerd in: (2010-12-01)

SMOD - data augmentation based on statistical models of deformation to enhance segmentation in 2D cine cardiac MRI
door: Corral Acero, J, et al.
Gepubliceerd in: (2019)

Mitigating Paxlovid™-induced drug‒drug interaction toxicity: an in silico insight
door: Giang H. Ta, et al.
Gepubliceerd in: (2024-11-01)

In silico Prioritization of Transporter–Drug Relationships From Drug Sensitivity Screens
door: Adrián César-Razquin, et al.
Gepubliceerd in: (2018-09-01)

Comparison of the simulated response of three in silico human stem cell-derived cardiomyocytes models and in vitro data under 15 drug actions
door: Paci, M, et al.
Gepubliceerd in: (2021)

Multiscale modelling of β-adrenergic stimulation in cardiac electromechanical function
door: Doste, R, et al.
Gepubliceerd in: (2021)

Multiscale Modelling of β-Adrenergic Stimulation in Cardiac Electromechanical Function
door: Ruben Doste, et al.
Gepubliceerd in: (2021-07-01)